aluates Reports

$ 0.0

Automative

Global Systemic Autoinflammatory Diseases Drug Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-22A18402

BUY CHAPTERS

Global Systemic Autoinflammatory Diseases Drug Market Research Report 2024

Code: QYRE-Auto-22A18402

Report

November 2024

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Group

FMF

Novartis

AbbVie

Abbott Laboratories

Regeneron Pharmaceuticals

Swedish Orphan Biovitrum AB

Pfizer Inc

Bausch Health

Mallinckrodt plc

Johnson & Johnson

Systemic Autoinflammatory Diseases Drug Market Size

The global Systemic Autoinflammatory Diseases Drug market was valued at US$ 13540 million in 2023 and is anticipated to reach US$ 18790 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.

Systemic Autoinflammatory Diseases Drug Market

Systemic autoinflammatory disease drugs are medications used to treat a group of conditions characterized by inappropriate and chronic activation of the body’s innate immune system, leading to widespread inflammation in various organs. Unlike autoimmune diseases, which are driven by the adaptive immune system attacking self-antigens, autoinflammatory diseases originate from innate immune dysregulation. Common conditions include familial Mediterranean fever (FMF), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), and systemic juvenile idiopathic arthritis (sJIA). These drugs, often targeting inflammatory pathways, aim to control flare-ups, reduce inflammation, and prevent long-term organ damage.

North American market for Systemic Autoinflammatory Diseases Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Systemic Autoinflammatory Diseases Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Systemic Autoinflammatory Diseases Drug in Ulcerative Colitis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Systemic Autoinflammatory Diseases Drug include Novartis, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, Swedish Orphan Biovitrum AB, Pfizer, Inc., Bausch Health, Mallinckrodt, Johnson & Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Systemic Autoinflammatory Diseases Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Autoinflammatory Diseases Drug.

The Systemic Autoinflammatory Diseases Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Systemic Autoinflammatory Diseases Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Systemic Autoinflammatory Diseases Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Systemic Autoinflammatory Diseases Drug Market Report

Report Metric	Details
Report Name	Systemic Autoinflammatory Diseases Drug Market
Accounted market size in 2023	US$ 13540 million
Forecasted market size in 2030	US$ 18790 million
CAGR	4.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Injectables Oral Other
Segment by Application	Ulcerative Colitis Juvenile Rheumatoid Arthritis Psoriatic Arthritis Other Indications
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, Swedish Orphan Biovitrum AB, Pfizer, Inc., Bausch Health, Mallinckrodt, Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Systemic Autoinflammatory Diseases Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Systemic Autoinflammatory Diseases Drug Market growing?

Ans: The Systemic Autoinflammatory Diseases Drug Market witnessing a CAGR of 4.6% during the forecast period 2024-2030.

What is the Systemic Autoinflammatory Diseases Drug Market size in 2030?

Ans: The Systemic Autoinflammatory Diseases Drug Market size in 2030 will be US$ 18790 million.

Who are the main players in the Systemic Autoinflammatory Diseases Drug Market report?

Ans: The main players in the Systemic Autoinflammatory Diseases Drug Market are Novartis, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, Swedish Orphan Biovitrum AB, Pfizer, Inc., Bausch Health, Mallinckrodt, Johnson & Johnson

What are the Application segmentation covered in the Systemic Autoinflammatory Diseases Drug Market report?

Ans: The Applications covered in the Systemic Autoinflammatory Diseases Drug Market report are Ulcerative Colitis, Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Other Indications

What are the Type segmentation covered in the Systemic Autoinflammatory Diseases Drug Market report?

Ans: The Types covered in the Systemic Autoinflammatory Diseases Drug Market report are Injectables, Oral, Other

Recommended Reports

Autoimmune Diseases

Inflammatory Diseases

Neurometabolic Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Injectables

1.2.3 Oral

1.2.4 Other

1.3 Market by Application

1.3.1 Global Systemic Autoinflammatory Diseases Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Ulcerative Colitis

1.3.3 Juvenile Rheumatoid Arthritis

1.3.4 Psoriatic Arthritis

1.3.5 Other Indications

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Systemic Autoinflammatory Diseases Drug Market Perspective (2019-2030)

2.2 Global Systemic Autoinflammatory Diseases Drug Growth Trends by Region

2.2.1 Global Systemic Autoinflammatory Diseases Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Systemic Autoinflammatory Diseases Drug Historic Market Size by Region (2019-2024)

2.2.3 Systemic Autoinflammatory Diseases Drug Forecasted Market Size by Region (2025-2030)

2.3 Systemic Autoinflammatory Diseases Drug Market Dynamics

2.3.1 Systemic Autoinflammatory Diseases Drug Industry Trends

2.3.2 Systemic Autoinflammatory Diseases Drug Market Drivers

2.3.3 Systemic Autoinflammatory Diseases Drug Market Challenges

2.3.4 Systemic Autoinflammatory Diseases Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Systemic Autoinflammatory Diseases Drug Players by Revenue

3.1.1 Global Top Systemic Autoinflammatory Diseases Drug Players by Revenue (2019-2024)

3.1.2 Global Systemic Autoinflammatory Diseases Drug Revenue Market Share by Players (2019-2024)

3.2 Global Systemic Autoinflammatory Diseases Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Systemic Autoinflammatory Diseases Drug Revenue

3.4 Global Systemic Autoinflammatory Diseases Drug Market Concentration Ratio

3.4.1 Global Systemic Autoinflammatory Diseases Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Systemic Autoinflammatory Diseases Drug Revenue in 2023

3.5 Global Key Players of Systemic Autoinflammatory Diseases Drug Head office and Area Served

3.6 Global Key Players of Systemic Autoinflammatory Diseases Drug, Product and Application

3.7 Global Key Players of Systemic Autoinflammatory Diseases Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Systemic Autoinflammatory Diseases Drug Breakdown Data by Type

4.1 Global Systemic Autoinflammatory Diseases Drug Historic Market Size by Type (2019-2024)

4.2 Global Systemic Autoinflammatory Diseases Drug Forecasted Market Size by Type (2025-2030)

5 Systemic Autoinflammatory Diseases Drug Breakdown Data by Application

5.1 Global Systemic Autoinflammatory Diseases Drug Historic Market Size by Application (2019-2024)

5.2 Global Systemic Autoinflammatory Diseases Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Systemic Autoinflammatory Diseases Drug Market Size (2019-2030)

6.2 North America Systemic Autoinflammatory Diseases Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024)

6.4 North America Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Systemic Autoinflammatory Diseases Drug Market Size (2019-2030)

7.2 Europe Systemic Autoinflammatory Diseases Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024)

7.4 Europe Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size (2019-2030)

8.2 Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Systemic Autoinflammatory Diseases Drug Market Size (2019-2030)

9.2 Latin America Systemic Autoinflammatory Diseases Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024)

9.4 Latin America Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size (2019-2030)

10.2 Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Systemic Autoinflammatory Diseases Drug Introduction

11.1.4 Novartis Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Abbvie

11.2.1 Abbvie Company Details

11.2.2 Abbvie Business Overview

11.2.3 Abbvie Systemic Autoinflammatory Diseases Drug Introduction

11.2.4 Abbvie Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.2.5 Abbvie Recent Development

11.3 Abbott Laboratories

11.3.1 Abbott Laboratories Company Details

11.3.2 Abbott Laboratories Business Overview

11.3.3 Abbott Laboratories Systemic Autoinflammatory Diseases Drug Introduction

11.3.4 Abbott Laboratories Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.3.5 Abbott Laboratories Recent Development

11.4 Regeneron Pharmaceuticals

11.4.1 Regeneron Pharmaceuticals Company Details

11.4.2 Regeneron Pharmaceuticals Business Overview

11.4.3 Regeneron Pharmaceuticals Systemic Autoinflammatory Diseases Drug Introduction

11.4.4 Regeneron Pharmaceuticals Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.4.5 Regeneron Pharmaceuticals Recent Development

11.5 Swedish Orphan Biovitrum AB

11.5.1 Swedish Orphan Biovitrum AB Company Details

11.5.2 Swedish Orphan Biovitrum AB Business Overview

11.5.3 Swedish Orphan Biovitrum AB Systemic Autoinflammatory Diseases Drug Introduction

11.5.4 Swedish Orphan Biovitrum AB Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.5.5 Swedish Orphan Biovitrum AB Recent Development

11.6 Pfizer, Inc.

11.6.1 Pfizer, Inc. Company Details

11.6.2 Pfizer, Inc. Business Overview

11.6.3 Pfizer, Inc. Systemic Autoinflammatory Diseases Drug Introduction

11.6.4 Pfizer, Inc. Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.6.5 Pfizer, Inc. Recent Development

11.7 Bausch Health

11.7.1 Bausch Health Company Details

11.7.2 Bausch Health Business Overview

11.7.3 Bausch Health Systemic Autoinflammatory Diseases Drug Introduction

11.7.4 Bausch Health Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.7.5 Bausch Health Recent Development

11.8 Mallinckrodt

11.8.1 Mallinckrodt Company Details

11.8.2 Mallinckrodt Business Overview

11.8.3 Mallinckrodt Systemic Autoinflammatory Diseases Drug Introduction

11.8.4 Mallinckrodt Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.8.5 Mallinckrodt Recent Development

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Details

11.9.2 Johnson & Johnson Business Overview

11.9.3 Johnson & Johnson Systemic Autoinflammatory Diseases Drug Introduction

11.9.4 Johnson & Johnson Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

11.9.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Group

FMF

Novartis

AbbVie

Abbott Laboratories

Regeneron Pharmaceuticals

Swedish Orphan Biovitrum AB

Pfizer Inc

Bausch Health

Mallinckrodt plc

Johnson & Johnson

List of Tables

Table 1. Global Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Injectables

Table 3. Key Players of Oral

Table 4. Key Players of Other

Table 5. Global Systemic Autoinflammatory Diseases Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Systemic Autoinflammatory Diseases Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Systemic Autoinflammatory Diseases Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Systemic Autoinflammatory Diseases Drug Market Share by Region (2019-2024)

Table 9. Global Systemic Autoinflammatory Diseases Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Systemic Autoinflammatory Diseases Drug Market Share by Region (2025-2030)

Table 11. Systemic Autoinflammatory Diseases Drug Market Trends

Table 12. Systemic Autoinflammatory Diseases Drug Market Drivers

Table 13. Systemic Autoinflammatory Diseases Drug Market Challenges

Table 14. Systemic Autoinflammatory Diseases Drug Market Restraints

Table 15. Global Systemic Autoinflammatory Diseases Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Systemic Autoinflammatory Diseases Drug Market Share by Players (2019-2024)

Table 17. Global Top Systemic Autoinflammatory Diseases Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Autoinflammatory Diseases Drug as of 2023)

Table 18. Ranking of Global Top Systemic Autoinflammatory Diseases Drug Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Systemic Autoinflammatory Diseases Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Systemic Autoinflammatory Diseases Drug, Headquarters and Area Served

Table 21. Global Key Players of Systemic Autoinflammatory Diseases Drug, Product and Application

Table 22. Global Key Players of Systemic Autoinflammatory Diseases Drug, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Systemic Autoinflammatory Diseases Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Systemic Autoinflammatory Diseases Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Systemic Autoinflammatory Diseases Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Systemic Autoinflammatory Diseases Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Systemic Autoinflammatory Diseases Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Systemic Autoinflammatory Diseases Drug Revenue Market Share by Application (2019-2024)

Table 30. Global Systemic Autoinflammatory Diseases Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Systemic Autoinflammatory Diseases Drug Revenue Market Share by Application (2025-2030)

Table 32. North America Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. Novartis Company Details

Table 48. Novartis Business Overview

Table 49. Novartis Systemic Autoinflammatory Diseases Drug Product

Table 50. Novartis Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Abbvie Company Details

Table 53. Abbvie Business Overview

Table 54. Abbvie Systemic Autoinflammatory Diseases Drug Product

Table 55. Abbvie Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 56. Abbvie Recent Development

Table 57. Abbott Laboratories Company Details

Table 58. Abbott Laboratories Business Overview

Table 59. Abbott Laboratories Systemic Autoinflammatory Diseases Drug Product

Table 60. Abbott Laboratories Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 61. Abbott Laboratories Recent Development

Table 62. Regeneron Pharmaceuticals Company Details

Table 63. Regeneron Pharmaceuticals Business Overview

Table 64. Regeneron Pharmaceuticals Systemic Autoinflammatory Diseases Drug Product

Table 65. Regeneron Pharmaceuticals Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 66. Regeneron Pharmaceuticals Recent Development

Table 67. Swedish Orphan Biovitrum AB Company Details

Table 68. Swedish Orphan Biovitrum AB Business Overview

Table 69. Swedish Orphan Biovitrum AB Systemic Autoinflammatory Diseases Drug Product

Table 70. Swedish Orphan Biovitrum AB Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 71. Swedish Orphan Biovitrum AB Recent Development

Table 72. Pfizer, Inc. Company Details

Table 73. Pfizer, Inc. Business Overview

Table 74. Pfizer, Inc. Systemic Autoinflammatory Diseases Drug Product

Table 75. Pfizer, Inc. Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 76. Pfizer, Inc. Recent Development

Table 77. Bausch Health Company Details

Table 78. Bausch Health Business Overview

Table 79. Bausch Health Systemic Autoinflammatory Diseases Drug Product

Table 80. Bausch Health Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 81. Bausch Health Recent Development

Table 82. Mallinckrodt Company Details

Table 83. Mallinckrodt Business Overview

Table 84. Mallinckrodt Systemic Autoinflammatory Diseases Drug Product

Table 85. Mallinckrodt Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 86. Mallinckrodt Recent Development

Table 87. Johnson & Johnson Company Details

Table 88. Johnson & Johnson Business Overview

Table 89. Johnson & Johnson Systemic Autoinflammatory Diseases Drug Product

Table 90. Johnson & Johnson Revenue in Systemic Autoinflammatory Diseases Drug Business (2019-2024) & (US$ Million)

Table 91. Johnson & Johnson Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Systemic Autoinflammatory Diseases Drug Picture

Figure 2. Global Systemic Autoinflammatory Diseases Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Systemic Autoinflammatory Diseases Drug Market Share by Type: 2023 VS 2030

Figure 4. Injectables Features

Figure 5. Oral Features

Figure 6. Other Features

Figure 7. Global Systemic Autoinflammatory Diseases Drug Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Systemic Autoinflammatory Diseases Drug Market Share by Application: 2023 VS 2030

Figure 9. Ulcerative Colitis Case Studies

Figure 10. Juvenile Rheumatoid Arthritis Case Studies

Figure 11. Psoriatic Arthritis Case Studies

Figure 12. Other Indications Case Studies

Figure 13. Systemic Autoinflammatory Diseases Drug Report Years Considered

Figure 14. Global Systemic Autoinflammatory Diseases Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Systemic Autoinflammatory Diseases Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Systemic Autoinflammatory Diseases Drug Market Share by Region: 2023 VS 2030

Figure 17. Global Systemic Autoinflammatory Diseases Drug Market Share by Players in 2023

Figure 18. Global Top Systemic Autoinflammatory Diseases Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Autoinflammatory Diseases Drug as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Systemic Autoinflammatory Diseases Drug Revenue in 2023

Figure 20. North America Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Systemic Autoinflammatory Diseases Drug Market Share by Country (2019-2030)

Figure 22. United States Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Systemic Autoinflammatory Diseases Drug Market Share by Country (2019-2030)

Figure 26. Germany Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Systemic Autoinflammatory Diseases Drug Market Share by Region (2019-2030)

Figure 34. China Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Systemic Autoinflammatory Diseases Drug Market Share by Country (2019-2030)

Figure 42. Mexico Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Systemic Autoinflammatory Diseases Drug Market Share by Country (2019-2030)

Figure 46. Turkey Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Systemic Autoinflammatory Diseases Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Novartis Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 50. Abbvie Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 51. Abbott Laboratories Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 52. Regeneron Pharmaceuticals Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 53. Swedish Orphan Biovitrum AB Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 54. Pfizer, Inc. Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 55. Bausch Health Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 56. Mallinckrodt Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 57. Johnson & Johnson Revenue Growth Rate in Systemic Autoinflammatory Diseases Drug Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Autoimmune Disease Drugs Market Research Report 2025

Global Tumor Necrosis Factor Alpha Inhibitors Market Research Report 2024

Global Anti Rheumatic Drugs Market Research Report 2024

Global Musculoskeletal System Disorder Drug Market Research Report 2024

Autoimmune Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antiinflammatory Drugs Market Insights Forecast to 2030

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Global Kinase Inhibitor in Autoimmune Diseases Market Research Report 2024

Global Lupus Therapeutic Market Research Report 2024

Global Tumor Necrosis Factor TNF Antagonists Market Research Report 2024

Systemic Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoimmunity Reagents Market Research Report 2024

Global Rare Inflammatory Disease Treatment Market Research Report 2024

Global Ophthalmic Anti inflammatories Market Research Report 2025

Systemic Corticosteroids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoimmune Diagnosis Reagents Market Research Report 2024

Global IL 17 Targeting Biological Drugs Market Research Report 2024

Global Tumor Necrosis Factor TNF Inhibitor Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions